Compare Baroda BNP Paribas Health and Wellness Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.78
2
NAV
₹10.50
₹506.49
Fund Started
09 Jun 2025
04 Jun 1999
Fund Size
₹553.17 Cr
₹4997.72 Cr
Exit Load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Exit load of 0.50% if redeemed within 15 days
1 Year
3.76%
14.90%
3 Year
-
23.86%
5 Year
-
16.41%
Equity
98.03%
97.16%
Cash
-0.58%
2.78%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 7.58% |
Lupin Ltd. | 6.56% |
Laurus Labs Ltd. | 6.31% |
Ipca Laboratories Ltd. | 5.80% |
Torrent Pharmaceuticals Ltd. | 5.43% |
Divi's Laboratories Ltd. | 5.35% |
Apollo Hospitals Enterprise Ltd. | 4.87% |
JB Chemicals & Pharmaceuticals Ltd. | 4.57% |
Fortis Healthcare Ltd. | 4.32% |
Astrazeneca Pharma India Ltd. | 3.87% |
Sun Pharmaceutical Industries Ltd. | 11.18% |
Acutaas Chemicals Ltd. | 6.35% |
Divi's Laboratories Ltd. | 5.92% |
Apollo Hospitals Enterprise Ltd. | 5.21% |
Max Healthcare Institute Ltd. | 5.08% |
Aurobindo Pharma Ltd. | 4.17% |
Aster DM Healthcare Ltd. | 3.77% |
Laurus Labs Ltd. | 3.64% |
Cipla Ltd. | 3.52% |
Torrent Pharmaceuticals Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
09 Jun 2025
04 Jun 1999
